FDA’s Examples of Interacting Drugs and Other Substances Involving CYP Metabolic- and Transporter System-Based Pathways for Healthcare Professionals
Similar Posts
CDER SBIA Chronicles
FDA/CDER SBIA Chronicles, the bi-monthly newsletter of the CDER Small Business and Industry Assistance team, provides industry with useful information to assist in all aspects of drug marketing and regulationTopical Antiseptic Products: Hand Sanitizers and Antibacterial Soaps
This page outlines the deferral requests and advice letters issued by FDA to manufacturers of over-the-counter (OTC) topical antiseptic products. These products are categorized as either consumer or health care and they include rubs and washes.Darmerica, LLC – 716152 – 12/08/2025
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/MisbrandedLil’ Turtles Issues a Voluntary Recall Due to Undeclared Milk Allergen
Baltic, OH (Dec. 4, 2025) – Lil’ Turtles is recalling all lots of its Grandma Belle’s Tomato Basil Soup for misbranding due to the milk allergen not being declared on the label. The Grandma Belle’s Tomato Basil Soup was packaged in 17 oz glass jars.FDA In Brief: FDA requires new warnings for gabapentinoids about risk of respiratory depression
FDA is requiring new warnings about the risk of serious breathing difficulties that can lead to death in patients who use gabapentanoids with opioid pain medicines or other drugs that depress the central nervous system.Mahita LLC dba PushMyCart – 716286 – 11/17/2025
Unapproved New Drugs
